Contact the Editorial Desk

Editorial correspondence

AgeDefy Peptides welcomes correspondence on the research record: a citation quoted inaccurately, a regulatory detail that has gone out of date, or a peer-reviewed study on NAD+, MOTS-c, or related longevity-research molecules that belongs on the references page. Corrections that improve accuracy are the most useful messages we receive, and they are read seriously.

The most actionable notes specify three things: the page they concern, the passage in question, and the supporting citation — a DOI or PubMed identifier where available.

Editorial mailbox: editors@agedefypeptides.com

What this desk cannot do

AgeDefy Peptides is a literature digest, not a clinic or a vendor. Correspondence on the following falls outside what this site can address:

• Advice on, or commentary about, human use of any compound discussed here.
• Dosing, scheduling, or route recommendations for any individual.
• Diagnosis of any medical condition.
• Assistance sourcing, purchasing, or evaluating any research compound or supplement.
• Guidance for athletes on anti-doping matters (MOTS-c is treated as prohibited; any athlete should consult their sport's governing body).

Responses to editorial correspondence are not guaranteed and may be delayed; the mailbox is monitored intermittently. Readers seeking medical guidance should consult a licensed clinician in their own jurisdiction.